InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Duncan Gregory Scott, Chief Executive Officer. Insider active across 1 companies, notably Virios Therapeutics, Inc.. Cumulatively, 3 disclosures have been published. Total volume traded: €81k. The latest transaction was disclosed on 23 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
€31,7357,500 shares@ €4.231439.3% of flow
Common Stock
SEC:0001415889-22-005567:0·
Ideal exit: 17 Feb 2023 (T+270)
€24,4875,000 shares@ €4.8974100.0% of flow
Common Stock
SEC:0001415889-21-006172·
Ideal exit: 17 Sept 2022 (T+270)
€24,4875,000 shares@ €4.897430.3% of flow
Common Stock
SEC:0001415889-21-006172:0·
Ideal exit: 17 Sept 2022 (T+270)
3 of 3 declarations
About Duncan Gregory Scott
Gregory Scott Duncan is the Chief Executive Officer of Virios Therapeutics, Inc. He oversees the company's operations, which focuses on developing therapeutic treatments. Gregory Scott Duncan is responsible for the overall strategy and direction of the company, ensuring that research and development objectives are met.
